What is the price target for ENFN stock?
11 analysts have analysed ENFN and the average price target is 11.15 USD. This implies a price increase of 3.59% is expected in the next year compared to the current price of 10.76.
NYSE:ENFN • US2928121043
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENFUSION INC - CLASS A (ENFN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-01-13 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-12-23 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-12-18 | Stifel | Maintains | Buy -> Buy |
| 2024-03-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-02-28 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2024-01-30 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-12-20 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-11-07 | UBS | Initiate | Neutral |
| 2023-08-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-05-22 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-05-10 | Credit Suisse | Maintains | Neutral |
| 2023-04-03 | Piper Sandler | Initiate | Neutral |
| 2023-03-15 | JP Morgan | Initiate | Neutral |
| 2023-01-26 | Goldman Sachs | Maintains | Neutral |
| 2023-01-04 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-01-03 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-10-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-08-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-14 | Goldman Sachs | Maintains | Neutral |
| 2022-07-06 | Piper Sandler | Maintains | Overweight |
| 2022-05-13 | Credit Suisse | Maintains | Neutral |
| 2022-05-13 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-12-03 | Credit Suisse | Maintains | Neutral |
| 2021-12-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 150.3M 34.56% | 174.535M 16.12% | 201.611M 15.51% | 241.06M 19.57% | 280.22M 16.24% | 318.66M 13.72% | |
| EBITDA YoY % growth | -5.66M 97.92% | 21.935M 487.54% | 17.909M -18.35% | 53.462M 198.52% | 69.374M 29.76% | 83.735M 20.70% | |
| EBIT YoY % growth | -12M 95.65% | 11.948M 199.57% | 6.155M -48.49% | 41.56M 575.22% | 55.822M 34.32% | 70.014M 25.42% | |
| Operating Margin | -7.98% | 6.85% | 3.05% | 17.24% | 19.92% | 21.97% | |
| EPS YoY % growth | 0.11 -11.68% | 0.14 25.00% | 0.19 35.71% | 0.29 50.32% | 0.37 31.25% | 0.40 6.12% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 6.25% | 0.07 32.60% | 0.07 45.35% | 0.08 183.32% | 0.09 40.00% | 0.10 46.15% | 0.11 47.37% | 0.12 38.01% |
| Revenue Q2Q % growth | 56.08M 16.71% | 58.856M 19.01% | 61.557M 20.31% | 64.617M 22.06% | 66.499M 18.58% | 69.595M 18.25% | 73.157M 18.84% | 77.382M 19.75% |
| EBITDA Q2Q % growth | 12.473M 699.04% | 12.784M 54.96% | 13.801M 20.13% | 15.567M 16.71% | 15.61M 25.15% | 16.966M 32.71% | 18.472M 33.85% | 20.313M 30.49% |
| EBIT Q2Q % growth | 9.481M 951.84% | 9.904M 266.41% | 10.911M 266.02% | 12.382M 681.69% | 12.368M 30.45% | 13.616M 37.48% | 15.009M 37.56% | 16.655M 34.51% |
All data in USD
11 analysts have analysed ENFN and the average price target is 11.15 USD. This implies a price increase of 3.59% is expected in the next year compared to the current price of 10.76.
ENFUSION INC - CLASS A (ENFN) will report earnings on 2025-05-08, before the market open.
The consensus EPS estimate for the next earnings of ENFUSION INC - CLASS A (ENFN) is 0.06 USD and the consensus revenue estimate is 56.08M USD.
The consensus rating for ENFUSION INC - CLASS A (ENFN) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.